WHO Drug Information, Vol. 18, No. 1, 2004                                                 Recommended INN: List 51



International Nonproprietary Names for
Pharmaceutical Substances (INN)
RECOMMENDED International Nonproprietary Names:
List 51
Notice is hereby given that, in accordance with paragraph 7 of the Procedure for the Selection of Recommended
International Nonproprietary Names for Pharmaceutical Substances Off. Rec. Wld Health Org., 1955, 60, 3 (Resolution
                                                                     [
EB15.R7); 1969, 173, 10 (Resolution EB43.R9)], the following names are selected as Recommended International
Nonproprietary Names. The inclusion of a name in the lists of Recommended International Nonproprietary Names does not
imply any recommendation of the use of the substance in medicine or pharmacy.
Lists of Proposed (1–85) and Recommended (1–45) International Nonproprietary Names can be found in Cumulative List
No. 10, 2002 (available in CD- ROM only).



Dénominations communes internationales
des Substances pharmaceutiques (DCI)
Dénominations communes internationales RECOMMANDÉES:
Liste 51
Il est notifié que, conformément aux dispositions du paragraphe 7 de la Procédure à suivre en vue du choix de
Dénominations communes internationales recommandées pour les Substances pharmaceutiques [Actes off. Org. mond.
Santé, 1955, 60, 3 (résolution EB15.R7); 1969, 173, 10 (résolution EB43.R9)] les dénominations ci-dessous sont choisies
par l’Organisation mondiale de la Santé en tant que dénominations communes internationales recommandées. L’inclusion
d’une dénomination dans les listes de DCI recommandées n’implique aucune recommandation en vue de l’utilisation de la
substance correspondante en médecine ou en pharmacie.
On trouvera d’autres listes de Dénominations communes internationales proposées (1–85) et recommandées (1–45) dans
la Liste récapitulative No. 10, 2002 (disponible sur CD-ROM seulement).



Denominaciones Comunes Internacionales
para las Sustancias Farmacéuticas (DCI)
Denominaciones Comunes Internacionales RECOMENDADAS:
Lista 51
De conformidad con lo que dispone el párrafo 7 del Procedimiento de Selección de Denominaciones Comunes
Internacionales R ecomendadas para las Sustancias Farmacéuticas [ ct. Of. Mund. Salud, 1955, 60, 3 (Resolución
                                                                        A
EB15.R7); 1969, 173, 10 (Resolución EB43.R9)], se comunica por el presente anuncio que las denominaciones que a
continuación se expresan han sido seleccionadas como Denominaciones Comunes Internacionales Recomendadas. La
inclusión de una denominación en las listas de las Denominaciones Comunes Recomendadas no supone recomendación
alguna en favor del empleo de la sustancia respectiva en medicina o en farmacia.
Las listas de Denominaciones Comunes Internacionales Propuestas (1–85) y Recomendadas (1–45) se encuentran
reunidas en Cumulative List No. 10, 2002 (disponible sólo en CD-ROM).




                                                                                                                    83
Recommended INN: List 51                                               WHO Drug Information, Vol. 18, No. 1, 2004




 Latin, English, French, Spanish:
 Recommended INN                    Chemical name or description; Molecular formula; Graphic formula

 DCI Recommandée                    Nom chimique ou description; Formule brute; Formule développée

                                    Nombre químico o descripción; Fórmula empírica; Fórmula desarrollada
 DCI Recomendada




 adargileukinum alfa
 adargileukin alfa                         [88-arginine]interleukin 2 (human clone pTIL2-21a) (partly
                                           glycosylated)

 adargileukine alfa                        [88-arginine]interleukine 2 humaine (clone pTIL2-21a) (en partie
                                           glycosylée)

 adargileukina alfa                        [88-arginina]interleukina 2 humana (clon pTIL2-21a) (parcialmente
                                           glicosilada)

                                           C695H1124N180O202S7 (peptide)

                                            APTSSSTKKT           QLQLEHLLLD            LQMILNGINN    YKNPKLTRML
                                            TFKFYMPKKA           TELKHLQCLE            EELKPLEEVL    NLAQSKNFHL
                                            RPRDLISRIN           VIVLELKGSE            TTFMCEYADE    TATIVEFLNR
                                            WITFCQSIIS           TLT


 alamifovirum
 alamifovir                                bis(2,2,2-trifluoroethyl) [(2-{2-amino-6-[(4-methoxyphenyl)sulfanyl]-
                                           9H-purin-9-yl}ethoxy)methyl]phosphonate

 alamifovir                                [[2-[2-amino-6-[(4-méthoxyphényl)sulfanyl]-9H-purin-
                                           9-yl]éthoxy]méthyl]phosphonate de bis(2,2,2-trifluoroéthyle)

 alamifovir                                [(2-{2-amino-6-[(4-metoxifenil)sulfanil]-9H-purin-
                                           9-il}etoxi)metil]fosfonato de bis(2,2,2-trifluoroetilo)

                                           C19H20F6N5O5 PS

                                            H3CO


                                                             S                             CF 3

                                                                   N           O
                                                         N                             O
                                                                                   P
                                                                                       O      CF 3
                                                   H2N       N     N       O




84
WHO Drug Information, Vol. 18, No. 1, 2004                                                Recommended INN: List 51




  aprinocarsenum
  aprinocarsen                               2'-deoxy-P-thioguanylyl-(3'→5')-P-thiothymidylyl-(3'→5')-
                                             P-thiothymidylyl-(3'→5')-2'-deoxy-P-thiocytidylyl-(3'→5')-
                                             P-thiothymidylyl-(3'→5')-2'-deoxy-P-thiocytidylyl-(3'→5')-2'- deoxy-
                                             P-thioguanylyl-(3'→5')-2'- deoxy-P-thiocytidylyl-(3'→5')-
                                             P-thiothymidylyl-(3'→5')-2'-deoxy-P-thioguanylyl-(3'→5')-2'- deoxy-
                                             P-thioguanylyl-(3'→5')-P-thiothymidylyl-(3'→5')-2'-deoxy-
                                             P-thioguanylyl-(3'→5')-2'- deoxy-P-thioadenylyl-(3'→5')-2'-deoxy-
                                             P-thioguanylyl-(3'→5')-P-thiothymidylyl-(3'→5')-P-thiothymidylyl-
                                             (3'→5')-P-thiothymidylyl-(3'→5')-2'-deoxy-P-thiocytidylyl-(3'→5')-
                                             2'-deoxyadenosine

  aprinocarsen                               2'-désoxy-P-thioadénylyl- (5'→3')-2'- désoxy-P-thiocytidylyl-(5'→3')-
                                             P-thiothymidylyl-(5'→3')-P-thiothymidylyl-(5'→3')-P-thiothymidylyl-
                                             (5'→3')-2'-désoxy-P-thioguanylyl-(5'→3')-2'- désoxy-P-thioadénylyl-
                                             (5'→3')-2'-désoxy-P-thioguanylyl-(5'→3')-P-thiothymidylyl-(5'→3')-
                                             2'-désoxy-P-thioguanylyl- (5'→3')-2'- désoxy-P-thioguanylyl-(5'→3')-
                                             P-thiothymidylyl-(5'→3')-2'-désoxy-P-thiocytidylyl-(5'→3')-2'-désoxy-
                                             P-thioguanylyl-(5'→3')-2'- désoxy-P-thiocytidylyl-(5'→3')-
                                             P-thiothymidylyl-(5'→3')-2'-désoxy-P-thiocytidylyl-(5'→3')-
                                             P-thiothymidylyl-(5'→3')-P-thiothymidylyl-(5'→3')-2'-
                                             désoxyguanosine

  aprinocarseno                              2'-desoxi-P-tioadenilil-(5'→3')-2'- desoxi-P-tiocitidilil-(5'→3')-
                                             P-tiotimidilil-(5'→3')-P-tiotimidilil-(5'→3')-P-tiotimidilil-(5'→3')-
                                             2'-desoxi-P-tioguanilil-(5'→3')-2'- desoxi-P-tioadenilil-(5'→3')-
                                             2'-desoxi-P-tioguanilil-(5'→3')-P-tiotimidilil-(5'→3')-2'-desoxi-
                                             P-tioguanilil-(5'→3')-2'- desoxi-P-tioguanilil-(5'→3')-P-tiotimidilil-
                                             (5'→3')-2'-desoxi-P-tiocitidilil-(5'→3')-2'-desoxi-P-tioguanilil-(5'→3')-
                                             2'-desoxi-P-tiocitidilil-(5'→3')-P-tiotimidilil-(5'→3')-2'- desoxi-
                                             P-tiocitidilil-(5'→3')-P-tiotimidilil-(5'→3')-P-tiotimidilil-(5'→3')-
                                             2'-desoxiguanosina

                                             C196H249N68O105P19S19




  belimumabum
  belimumab                                  immunoglobulin G1, anti-(human cytokine BAFF) (human
                                             monoclonal LymphoStat-B heavy chain), disulfide with human
                                             monoclonal LymphoStat-B λ-chain, dimer

  bélimumab                                  immunoglobuline G1, anti-(cytokine BAFF humaine) ; dimère du
                                             disulfure entre la chaîne lourde et la chaîne λ de l'anticorps
                                             monoclonal humain LymphoStat-B

  belimumab                                  immunoglobulina G1, anti-(citoquina BAFF humana) ; dímero del
                                             disulfuro entre la cadena pesada y la cadena λ del anticuerpo
                                             monoclonal humano LymphoStat-B




                                                                                                                         85
Recommended INN: List 51                                WHO Drug Information, Vol. 18, No. 1, 2004




 cantuzumabum mertansinum
 cantuzumab mertansine      immunoglobulin G1, anti-(mucin CanAg) (human-mouse
                            monoclonal C242 heavy chain), disulfide with human-mouse
                            monoclonal C242 light chain, dimer, conjugate at the 6-amino
                            groups of four lysine residues forming an amide bond with (4RS)-
                            4-[(3-{[(1S)-2-{[(1S,2R,3S,5S,6S,16E,18E,20R,21S)-11-chloro-
                            21-hydroxy-12,20-dimethoxy-2,5,9,16-tetramethyl-8,23-dioxo-
                            4,24-dioxa-9,22-diazatetracyclo[19.3.1.110,14.03,5 ]hexacosa-
                            10,12,14(26),16,18-pentaen-6-yl]oxy}-1-methyl-2-oxoethyl]=
                            methylamino}-3-oxopropyl)disulfanyl]pentanoyl groups

 cantuzumab mertansine      immunoglobuline G1, anti-(mucin CanAg) ; dimère du disulfure
                            entre la chaîne lourde et la chaîne légère de l'anticorps monoclonal
                            de souris C242 humanisé dont les groupes 6-amino de quatre
                            lysines sont amidifiés par l'acide (4RS)-4-[[3-[[(1S)-
                            2-[[(1S,2R,3S,5S,6S,16E,18E,20R,21S)-11-chloro-21-hydroxy-
                            12,20-diméthoxy-2,5,9,16-tétraméthyl-8,23-dioxo-4,24-dioxa-
                            9,22-diazatétracyclo[19.3.1.110,14.03,5]hexacosa-
                            10,12,14(26),16,18-pentaén-6-yl]oxy]-1-méthyl-2-oxoéthyl]=
                            méthylamino]-3-oxopropyl]disulfanyl]pentanoïque

 cantuzumab mertansina      inmunoglobulina G1, anti-(mucina CanAg) ; dímero del disulfuro
                            entre la cadena pesada y la cadena ligera del anticuerpo
                            monoclonal humanizado de ratón C242 en el que los grupos
                            6-amino de cuatro lisinas están amidificados por ácido (4RS)-
                            4-[[3-[[(1S)-2-[[(1S,2R,3S,5S,6S,16E,18E,20R,21S)-11-cloro-
                            21-hidroxi-2,5,9,16-tetrametil -12,20-dimetoxi-4,24-dioxa-
                            8,23-dioxo-9,22-diazatetraciclo[19.3.1.1 10,14.03,5 ]hexacosa-
                            10,12,14(26),16,18-pentaen-6-il]oxi]-1-metil-2-oxoetil]metilamino]-
                            3-oxopropil]disulfanil]pentanoico



                                     O                           O    H CH3
                                                S                              O
                            Ig   N                  S                N
                                 H
                                             CH3          H3C        CH3   O
                                                                               CH3   Cl
                                                             O             H
                                                    H3C                        N          OCH3
                                                                     H
                                                         H       H
                                                                           O
                                                         O
                                                                     OH
                                                    O        N
                                                             H   H OCH3            CH3
                                                                                            4

                                                 cantuzumab = Ig(NH2)4


 cimicoxibum
 cimicoxib                  4-[4-chloro-5-(3-fluoro-4-methoxyphenyl)-1H-imidazol-
                            1-yl]benzenesulfonamide

 cimicoxib                  4-[4-chloro-5-(3-fluoro-4-méthoxyphényl)-1H-imidazol-
                            1-yl]benzènesulfonamide

 cimicoxib                  4-[4-cloro-5-(3-fluoro-4-metoxifenil)-1H-imidazol-
                            1-il]bencenosulfonamida




86
WHO Drug Information, Vol. 18, No. 1, 2004                                                Recommended INN: List 51




                                             C16H13ClFN3O3S

                                              H 3CO

                                             F                            O O
                                                                           S
                                                                             NH 2


                                              Cl            N

                                                        N



  dabuzalgronum
  dabuzalgron                                N-{6-chloro-3-[(4,5-dihydro-1H-imidazol-2-yl)methoxy]-
                                             2-methylphenyl}methanesulfonamide

  dabuzalgron                                N-[6-chloro-3-[(4,5-dihydro-1H-imidazol-2-yl)méthoxy]-
                                             2-méthylphényl]méthanesulfonamide

  dabuzalgrón                                N-{6-cloro-3-[(4,5-dihidro-1H-imidazol-2-il)metoxi]-
                                             2-metilfenil}metanosulfonamida

                                             C12H16ClN3O3S

                                                                CH3           N
                                                        H
                                             H3C        N             O
                                                    S                             N
                                                                                  H
                                                   O O
                                                      Cl



  dacinostatum
  dacinostat                                 (2E)-N-hydroxy-3-[4-({(2-hydroxyethyl)[2-(1H-indol-
                                             3-yl)ethyl]amino}methyl)phenyl]propenamide

  dacinostat                                 (2E)-N-hydroxy-3-[4-[[(2-hydroxyéthyl)[2-(1H-indol-
                                             3-yl)éthyl]amino]méthyl]phényl]prop-2-énamide

  dacinostat                                 (2E)-N-hidroxi-3-[4-({(2-hidroxietil)[2-(1H-indol-
                                             3-il)etil]amino}metil)fenil]propenamida

                                             C22H25N3O3

                                                   HN

                                                                      N
                                                                                          H
                                                                                          N
                                                                                              OH
                                                                 OH                   O




                                                                                                               87
Recommended INN: List 51                                    WHO Drug Information, Vol. 18, No. 1, 2004




 dalbavancinum
 dalbavancin               5,31-dichloro-38-de(methoxycarbonyl)-7-demethyl-19-deoxy-56-O-
                           [2-deoxy-2-[(10-methylundecanoyl)amino]- ß- D -glucopyranuronosyl]-
                           38-[[3-(dimethylamino)propyl]carbamoyl]-42-O-a- D-mannopyranosyl-
                           15-Nmethyl(ristomycin A aglicone) (main component)

 dalbavancine              acide 2-désoxy-1-O-[(3S,15R,18R,34R,35S,38S,48R,50aR)-5,31-
                           dichloro-38-[[3-(diméthylamino)propyl]carbamoyl]-6,11,34,40,44-
                           pentahydroxy-42-(a- D-mannopyranosyloxy)-15-(méthylamino)-
                           2,16,36,50,51,59-hexaoxo-
                           2,3,16,17,18,19,35,36,37,38,48,49,50,50a-tétradécahydro-
                           20,23:30,33-diéthéno-3,18:35,48-bis(iminométhano)-
                           1H,15H-4,8:10,14:25,28:43,47-tétraméthéno-
                           34H-[1,14,6,22]dioxadiazacyclooctacosino[4,5-m][10,2,16]=
                           benzoxadiazacyclotétracosén-56-yl]-2-[(10-méthylundécanoyl)=
                           amino]-ß- D -glucopyranuronique (composant majeur)

 dalbavancina              ácido 1-O-[(3S,15R,18R,34R,35S,38S,48R,50aR)-5,31-dicloro-38-
                           [[3-(dimetilamino)propil]carbamoil]-6,11,34,40,44-pentahidroxi-42-
                           (a- D-manopiranosiloxi)-15-(metilamino)-2,16,36,50,51,59-hexaoxo-
                           2,3,16,17,18,19,35,36,37,38,48,49,50,50a-tetradecahidro-
                           20,23:30,33-dieteno-3,18:35,48-bis(iminometano) -1H,15H-
                           4,8:10,14:25,28:43,47-tetrameteno-
                           34H-[1,14,6,22]dioxadiazaciclooctacosino[4,5-m][10,2,16]=
                           benzoxadiazaciclotetracosen-56-il]-2-[(10-metilundecanoil)amino]-
                           2-desoxi-ß-D -glucopiranurónico (componente principal)

                           C88-H100-Cl2-N10-O28

                                        HO

                                                       O
                                                 OH HO
                                        HO
                                       HO                  O
                                                                OH                                        OH
                                            O                                                   O
                                                                              HO
                                       HN
                                            HN         H                       Cl
                                                                         O                  O
                                                     H H             H        H H       H       H H        H
                           H3C                         N                        N                 N             CH3
                                            O                        N                  N                  N
                                 N
                                                                     H                  H                  H
                                 CH3                       O                        O                 O
                                            HO
                                                 H
                                                                 O                  O
                                                           Cl    CO2H
                                                                              O
                                                                          O
                                                                 OH
                                                            HO                                            CH3
                                                                         HN
                                                                                                               CH3
                                                                              O




88
WHO Drug Information, Vol. 18, No. 1, 2004                                                  Recommended INN: List 51




  deligoparinum natricum
  deligoparin sodium                         sodium salt of depolymerised heparin obtained by a controlled
                                             chemical process based on generation of free radicals by means of
                                             metal ions and hydrogen peroxide. The heparin starting material is
                                             obtained from porcine intestinal mucosa. The process results in
                                             oligosaccharide fragments of heparin of varying lengths. The
                                             average relative molecular mass is about 3200 Daltons, ranging from
                                             2250 to 3850 Daltons. The degree of sulfation is approximately 2.5
                                             sulfate residues per disaccharide unit.

  déligoparine sodique                       sel de sodium d'héparine de basse masse moléculaire obtenue par
                                             par dépolymérisation à l'aide de radicaux libres (générés par des
                                             ions métalliques et du peroxyde d'hydrogène) d'héparine de
                                             muqueuse intestinale de porc. La majorité des composants
                                             présentent une structure acide 2-O-sulfo-α-D -glucopyranosuronique
                                             à l'extrémité non réductrice et une structure 2-désoxy-6-O-sulfo-2-
                                             (sulfoamino)- D-glucopyranose à l'extrémité réductrice de leur
                                             chaîne ; la masse moléculaire relative moyenne est voisine de
                                             3200 (2250 à 3850) ; le degré de sulfatation est voisin de 2,5 par
                                             unité disaccharide.

  deligoparina sódica                        sal sódica de una heparina de baja masa molecular que se obtiene
                                             de la heparina de la mucosa intestinal porcina por
                                             despolimerización por radicales libres, generados por iones
                                             metálicos y peróxido de hidrógeno; la mayoría de los componentes
                                             tienen una estructura de ácido 2- O -sulfo-α-D -glucopiranosurónico
                                             en el extremo no-reductor de la cadena y una estructura 2-desoxy-
                                             6-O-sulfo-2-(sulfoamino)-D -glucopiranosa en el reductor; la masa
                                             molecular media oscila entre 2250 y 3850, con un valor
                                             característico de unos 3200; el grado de sulfatación es alrededor
                                             de 2,5 por unidad de disacárido.




  desvenlafaxinum
  desvenlafaxine                             4-[(1RS)-2-(dimethylamino)-1-(1-hydroxycyclohexyl)ethyl]phenol

  dèsvenlafaxine                             4-[(1RS)-2-(diméthylamino)-1-(1-hydroxycyclohexyl)éthyl]phénol

  desvenlafaxina                             4-[(1RS)-2-(dimetilamino)-1-(1-hidroxiciclohexil)etil]fenol

                                             C16H25NO2


                                                           OH
                                                            H    CH3      and enantiomer
                                                                 N        et énanti omère
                                                                     CH 3 y enantiómero

                                             HO

  diboterminum alfa
  dibotermin alfa                            human recombinant bone morphogenic protein-2 (hrBMP-2)

  dibotermine alfa                           protéine-2 humaine recombinante morphogénique de l'os (PMOrh-
                                             2)

  dibotermina alfa                           proteína-2 humana recombinante morfogénica de hueso (PMOrh-2)




                                                                                                                   89
Recommended INN: List 51                                          WHO Drug Information, Vol. 18, No. 1, 2004




                           [C571H886 N160O 164 S9]2

                           QAKHKQRKRL                KSSCKRHPLY             VDFSDVGWND              WIVAPPGYHA
                           FYCHGECPFP                LADHLNSTNH             AIVQTLVNSV              NSKIPKACCV
                           PTELSAISML                YLDENEKVVL             KNYQDMVVEG               CGCR


 diquafosolum
 diquafosol                P1,P4-bis(5'-uridyl) tetrahydrogen tetraphosphate

 diquafosol                uridine(5')tétraphospho(5')uridine

 dicuafosol                tetrahidrógenotetrafosfato de P1,P4-bis(5'-uridilo)

                           C18H26N4O23 P4

                                       HO       O                       H
                                            P                 O         N   O
                                       O         O
                                      OP     O                      N
                                   O
                                     OH
                                P O
                              O          HO H                     OH
                                  OH
                           O P          O    N                     O
                                O
                           HO
                                      O    N


                                    HO              OH



 disermolidum
 disermolide               (3Z,5S,6S,7S,8R,9S,11Z,13S,14S,15S,16Z,18S)-8,14,18-
                           trihydroxy-19-[(2S,3R,4S,5R)-4-hydroxy-3,5-dimethyl-
                           6-oxotetrahydro-2H-pyran-2-yl]-5,7,9,11,13,15-
                           hexamethylnonadeca-1,3,11,16-tetraen-6-yl carbamate

 disermolide               carbamate de (1S,2S,3R,4S,6Z,8S,9S,10S,11Z,13S)-3,9,13-
                           trihydroxy-14-[(2S,3R,4S,5R)-4-hydroxy-3,5-diméthyl-
                           6-oxotétrahydro-2H-pyran-2-yl]-2,4,6,8,10-pentaméthyl-
                           1-[(1S,2Z)-1-méthylpenta-2,4-diényl]tétradéca-6,11-diényle

 disermolida               carbamato de (3Z,5S,6S,7S,8R,9S,11Z,13S,14S,15S,16Z,18S)-
                           8,14,18-trihidroxi-19-[(2S,3R,4S,5R)-4-hidroxi-3,5-dimetil-
                           6-oxotetrahidro-2H-piran-2-il]-5,7,9,11,13,15-hexametilnonadeca-
                           1,3,11,16-tetraen-6-ilo

                           C33H55NO8

                           H2C                                                                      CH3
                                           CH3       CH3 CH3 CH3
                                       H               H   H                                    H     H
                                                                                                          OH
                                                     H        H         H            H      H             H
                                  H2N           O        OH                            OH       O
                                                                   H3C               CH3                  H
                                                                                 H                      CH3
                                           O                                OH                      O




90
WHO Drug Information, Vol. 18, No. 1, 2004                                                   Recommended INN: List 51




  edifoligidum
  edifoligide                                duplex of 2'-deoxy-P-thiocytidylyl-(3'→5')-P-thiothymidylyl-(3'→5')-
                                             2'-deoxy-P-thioadenylyl-(3'→5')-2'-deoxy-P-thioguanylyl- (3'→5')-
                                             2'-deoxy-P-thioadenylyl-(3'→5')-P-thiothymidylyl-(3'→5')-
                                             P-thiothymidylyl-(3'→5')-P-thiothymidylyl-(3'→5')-2'- deoxy-
                                             P-thiocytidylyl-(3'→5')-2'- deoxy-P-thiocytidylyl-(3'→5')-2'-deoxy-
                                             P-thiocytidylyl-(3'→5')-2'- deoxy-P-thioguanylyl-(3'→5')-2'-deoxy-
                                             P-thiocytidylyl-(3'→5')-2'- deoxyguanosine and 2'- deoxy-
                                             P-thioguanylyl-(3'→5')-2'- deoxy-P-thioadenylyl-(3'→5')-
                                             P-thiothymidylyl-(3'→5')-2'-deoxy-P-thiocytidylyl-(3'→5')-2'- deoxy-
                                             P-thiocytidylyl-(3'→5')-2'- deoxy-P-thioguanylyl-(3'→5')-2'-deoxy-
                                             P-thiocytidylyl-(3'→5')-2'- deoxy-P-thioguanylyl-(3'→5')-2'-deoxy-
                                             P-thioguanylyl-(3'→5')-2'- deoxy-P-thioguanylyl-(3'→5')-2'-deoxy-
                                             P-thioadenylyl-(3'→5')-2'- deoxy-P-thioadenylyl-(3'→5')-2'-deoxy-
                                             P-thioadenylyl-(3'→5') -thymidine

  édifoligide                                2'-désoxy-P-thiocytidylyl-(3'→5')-P-thiothymidylyl-(3'→5')-2'-désoxy-
                                             P-thioadénylyl-(3'→5')-2'- désoxy-P-thioguanylyl-(3'→5')-2'-désoxy-
                                             P-thioadénylyl-(3'→5')-P-thiothymidylyl-(3'→5')-P-thiothymidylyl-
                                             (3'→5')-P-thiothymidylyl-(3'→5')-2'-désoxy-P-thiocytidylyl-(3'→5')-
                                             2'-désoxy-P-thiocytidylyl-(3'→5')-2'- désoxy-P-thiocytidylyl-(3'→5')-
                                             2'-désoxy-P-thioguanylyl- (3'→5')-2'- désoxy-P-thiocytidylyl-(3'→5')-
                                             2'-désoxyguanosine et P-thiothymidylyl-(5'→3')-2'- désoxy-
                                             P-thioadénylyl-(5'→3')-2'- désoxy-P-thioadénylyl-(5'→3')-2'-désoxy-
                                             P-thioadénylyl-(5'→3')-2'- désoxy-P-thioguanylyl-(5'→3')-2'-désoxy-
                                             P-thioguanylyl-(5'→3')-2'- désoxy-P-thioguanylyl-(5'→3')-2'-désoxy-
                                             P-thiocytidylyl-(5'→3')-2'- désoxy-P-thioguanylyl-(5'→3')-2'-désoxy-
                                             P-thiocytidylyl-(5'→3')-2'- désoxy-P-thiocytidylyl-(5'→3')-
                                             P-thiothymidylyl-(5'→3')-2'-désoxy-P-thioadénylyl-(5'→3')-
                                             2'-désoxyguanosine partiellement complémentaires

  edifoligida                                2'-desoxi-P-tiocitidilil-(3'→5')-P-tiotimidilil-(3'→5')-2'- desoxi-
                                             P-tioadenilil-(3'→5')-2'- desoxi-P-tioguanilil-(3'→5')-2'- deoxi-
                                             P-tioadenilil-(3'→5')-P-tiotimidilil-(3'→5')-P-tiotimidilil-(3'→5')-
                                             P-tiotimidilil-(3'→5')-2'- desoxi-P-tiocitidilil-(3'→5')-2'- desoxi-P-
                                             tiocitidilil-(3'→5')-2'-desoxi-P-tiocitidilil-(3'→5')-2'-desoxi-P-tioguanilil-
                                             (3'→5')-2'-desoxi-P-tiocitidilil-(3'→5')-2'-desoxiguanosina y
                                             P-tiotimidilil-(5'→3')-2'- desoxi-P-tioadenilil-(5'→3')-2'-desoxi-
                                             P-tioadenilil-(5'→3')-2'- desoxi-P-tioadenilil-(5'→3')-2'- desoxi-
                                             P-tioguanilil-(5'→3')-2'- desoxi-P-tioguanill-(5'→3')-2'-disoxi-
                                             P-tioguanilil-(5'→3')-2'- desoxi-P-tiocitidilil-(5'→3')-2'- desoxi-
                                             P-tioguanilil-(5'→3')-2'- desoxi-P-tiocitidilil-(5'→3')-2'- desoxi-
                                             P-tiocitidilil-(5'→3')-P-tiotimidilil-(5'→3')-2'- desoxi-P-tioadenilil-
                                             (5'→3')-2'-desoxiguanosina parcialmente complementario


                                                                           . . . T C C C G C. G)
                                             (3'-5')d(P-thio) (C T A G A T T
                                                                                 . . . . . .
                                                          (5'-3')d(P-thio) (T   A A A G G G C G C C T A G)




                                                                                                                          91
Recommended INN: List 51                                     WHO Drug Information, Vol. 18, No. 1, 2004




 edotecarinum
 edotecarin                12-ß-D -glucopyranosyl-2,10-dihydroxy-6-[[2-hydroxy-
                           1-(hydroxymethyl)ethyl]amino]-12,13-dihydro-
                           6H-indolo[2,3-a]pyrrolo[3,4-c]carbazole-5,7-dione

 édotécarine               12-ß-D -glucopyranosyl-2,10-dihydroxy-6-[[2-hydroxy-
                           1-(hydroxyméthyl)éthyl]amino]-12,13-dihydro-
                           6H-indolo[2,3-a]pyrrolo[3,4-c]carbazole-5,7-dione

 edotecarina               12-ß-D -glucopiranosil-2,10-dihidroxi-6-[[2-hidroxi-
                           1-(hidroximetil)etil]amino]-12,13-dihidro-6H-indolo[2,3-a]pirrolo=
                           [3,4-c]carbazol-5,7-diona

                           C29 H2 8N4O1 1

                            HO
                                                   O         H
                                                             N
                                                         N                OH
                                    HN
                           HO                                O       OH

                                       O N
                                 OH
                           HO
                                       OH          OH




 edratidum
 edratide                  glycyl- L-tyrosyl- L-tyrosyl- L-tryptophyl- L-seryl- L-tryptophyl-L-isoleucyl-
                           L-arginyl- L-glutaminyl- L-prolyl- L-prolylglycyl- L-lysylglycyl- L-glutamyl-
                           L-glutamyl- L-tryptophyl- L-isoleucylglycine

 édratide                  glycyl- L-tyrosyl- L-tyrosyl- L-tryptophyl- L-séryl- L-tryptophyl-L-isoleucyl-
                           L-arginyl- L-glutaminyl- L-prolyl- L-prolyl-glycyl L-lysyl-glycyl-
                                                                              -
                           L-glutamyl- L-glutamyl- L-tryptophyl-L-isoleucyl-glycine

 edratida                  glicil- L-tirosil- L-tirosil- L-triptofil- L-seril- L-triptofil- L-isoleucil- L-arginil-
                           L-glutaminil- L-prolil- L-prolilglicil- L-lisilglicil- L-glutamil- L-glutamil-
                           L-triptofil- L-isoleucilglicina

                           C111H149N27O28

                           H Gly     Tyr    Tyr    Trp    Ser      Trp    Ile     Arg     Gln   Pro
                                                                                                10

                              Pro     Gly    Lys    Gly      Glu    Glu     Trp     Ile   Gly OH
                                                                                           19




92
WHO Drug Information, Vol. 18, No. 1, 2004                                              Recommended INN: List 51




  elsilimomabum
  elsilimomab                                immunoglobulin G1, anti-(human interleukin 6) (mouse monoclonal
                                             B-E8 heavy chain), disulfide with mouse monoclonal B-E8 κ-chain,
                                             dimer

  elsilimomab                                immunoglobuline G1, anti-(interleukine 6 humaine) ; dimère du
                                             disulfure entre la chaîne lourde et la chaîne κ de l'anticorps
                                             monoclonal de souris B-E8

  elsilimomab                                inmunoglobulina G1, anti-(interleuquina 6 humana) ; dímero del
                                             disulfuro entre la cadena pesada y la cadena κ del anticuerpo
                                             monoclonal de ratón B-E8




  elvucitabinum
  elvucitabine                               4-amino-5-fluoro-1-[(2S,5R)-5-(hydroxymethyl)-2,5-dihydro-
                                             2-furyl]pyrimidin-2(1H)-one

  elvucitabine                               4-amino-5-fluoro-1-[(2S,5R)-5-(hydroxyméthyl)-2,5-dihydrofuran-
                                             2-yl]pyrimidin-2(1H)-one

  elvucitabina                               4-amino-5-fluoro-1-[(2S,5R)-5-(hidroximetil)-2,5-dihidro-
                                             2-furil]pirimidin-2(1H)-ona

                                             C9H10FN3O3

                                                           NH 2
                                                                   F
                                                       N

                                                   O       N
                                                               H
                                                       O

                                             HO   H



  epitumomabum cituxetanum
  epitumomab cituxetan                       Conjugate of 4-{(2RS)-2-[bis(carboxymethyl)amino]-3-({2-
                                             [bis(carboxymethyl)amino]ethyl}(carboxymethyl)amino)propyl}phen
                                             yl isothiocyanate forming a thiourea with the 6-amino of a lysine of
                                             immunoglobulin G1, anti-(human episialin) (mouse monoclonal
                                             HMFG-1 γ1-chain), disulfide with mouse monoclonal HMFG-1 light
                                             chain, dimer

  épitumomab cituxétan                       dérivé de la thiourée produite par réaction de l'isothiocyanate de
                                             4-[(2RS)-2-[bis(carboxyméthyl)amino]-3-[[2-[bis(carboxyméthyl)=
                                             amino]éthyl](carboxyméthyl)amino]propyl]phényle avec le 6-amino
                                             d'une lysine de l'immunoglobuline G1, anti-(human episialin) ;
                                             dimère du disulfure entre la chaîne γ1 et la chaîne légère de
                                             l'anticorps monoclonal de souris HMFG-1

  epitumomab cituxetán                       derivado de la tiourea producido por reacción del isotiocianato de
                                             4-[(2RS)-2-[bis(carboximetil)amino]-3-[[2-
                                             [bis(carboximetil)amino]etil](carboximetil)amino]propil]fenil con el
                                             6-amino de una lisina de la inmunoglobulina G1, anti-(episialina
                                             humana) ; dímero del disulfuro entre la cadena γ1 y la cadena
                                             ligera del anticuerpo monoclonal de ratón HMFG-1


                                                                                                                    93
Recommended INN: List 51                                          WHO Drug Information, Vol. 18, No. 1, 2004




                                                HO2C                                        CO2H

                                            HO 2C        N *                        N           CO2H
                                                                        N                                and epimer at C*
                                                                  H                                      et l'épimère en C*
                                        S                                                                y el epímero al C*
                                                                            CO 2H

                           Ig       N       N
                                    H       H                         epitumomab = Ig-NH2


 eptoterminum alfa
 eptotermin alfa           human recombinant bone morphogenetic protein 7 (hrBMP-7) or
                           osteogenic protein-1 (OP-1)

 eptotermine alfa          protéine-7 humaine recombinante morphogénique de l'os (PMOrh-
                           7) ou protéine-1 osteogénique (PO-1)

 eptotermina alfa          proteína-7 humana recombinante morfogénicas de hueso (PMOrh-
                           7) o proteína-1 osteogénica (PO-1)

                           [C683H1061N197O208S10]2

                                        H
                                                         N
                           HN
                                                         N
                                        H

 exatecanum alideximerum
 exatecan alideximer       exatecan linked via the tetrapeptide (glycylglycyl-
                           L-phenylalanylglycyl) to poly[oxy(2-hydroxymethylethylene)oxy=
                           (hydroxymethylmethylene)] partly O-substituted with carboxymethyl
                           groups with some carboxy groups amide linked to the tetrapeptide.

 exatécan alideximer       exatécan lié par une chaîne tétrapeptidique (glycylglycyl-
                           L-phénylalanylglycyl) à des éthers carboxyméthyliques de
                           poly[oxy(2-hydroxyéthylidène)oxy[1-(hydroxyméthyl)éthylène]]

 exatecán alidexímero      exatecán ligado por una cadena tetrapeptídica (glicilglicil-
                           L-fenilalanilglicil) a éteres carboximetílicos de poli[oxi-
                           (2-hidroxietilideno)oxi[1-(hidroximetil)etileno]]


                                            O       O

                                                                            R   =       -H
                                                    O         O                         -CH2-CO2H
                                                    R         R
                                                                  n                     or / ou / or :
                                CH2
                                                                                            O
                                        Gly Gly Phe Gly NH
                                                                            H
                                O
                                                                                        N                O

                                                                                                              O
                                                                                N               HO           CH3
                                                        H3C

                                                                  F



94
WHO Drug Information, Vol. 18, No. 1, 2004                                                        Recommended INN: List 51




  exenatidum
  exenatide                                  L-histidylglycyl- L-glutamylglycyl-L-threonyl L-phenylalanyl- L-threonyl-
                                                                                             -
                                             L-seryl L-aspartyl- L-leucyl- L-seryl L-lysyl- L-glutaminyl- L-methionyl-
                                                    -                              -
                                             L-glutamyl- L-glutamyl- L-glutamyl- L-alanyl- L-valyl- L-arginyl L-leucyl-
                                                                                                             -
                                             L-phenylalanyl- L-isoleucyl- L-glutamyl- L-tryptophyl- L-leucyl- L-lysyl-
                                             L-asparaginylglycylglycyl- L-prolyl- L-seryl- L-serylglycyl- L-alanyl-
                                             L-prolyl L-prolyl- L-prolyl- L-serinamide
                                                     -

  exénatide                                  exendine 4 (Heloderma suspectum), synthétique

  exenatida                                  L-histidilglicil- L-glutamilglicil- L-treonil- L-fenilalanil- L-treonil- L-seril-
                                             L-aspartil- L-leucil- L-seril- L-lisil- L-glutaminil- L-metionil- L-glutamil-
                                             L-glutamil- L-glutamil- L-alanil- L-valil- L-arginil- L-leucil- L-fenilalanil-
                                             L-isoleucil- L-glutamil- L-triptofil- L-leucil- L-lisil- L-asparaginilglicilglicil-
                                             L-prolil- L-seril- L-serilglicil- L-alanil- L-prolil- L-prolil- L-prolil- L-serinamida

                                             C184H282N50O60S

                                             H His Gly Glu Gly Th r Phe Th r Ser Asp Leu Ser Lys G ln Met
                                                                                                       10
                                                Glu Glu Gl u Ala Val Arg Leu Phe Ile Glu Trp Leu Lys Asn
                                                                               20
                                                Gly G ly Pro Ser Ser Gly            Ala Pro Pro Pr o Ser NH 2
                                                         30                                                  39




  firocoxibum
  firocoxib                                  3-(cyclopropylmethoxy)-5,5-dimethyl-4-[4-(methylsulfonyl)=
                                             phenyl]furan-2(5H)-one

  firocoxib                                  3-(cyclopropylméthoxy)-5,5-diméthyl-4-[4-(méthylsulfonyl)=
                                             phényl]furan-2(5H)-one

  firocoxib                                  3-(ciclopropilmetoxi)-5,5-dimetil-4-[4-(metilsulfonil)fenil]furan-2(5H)-
                                             ona

                                             C17H20O5S


                                                                      O O
                                                                         S
                                                     O                       CH3


                                              O
                                                     O          CH3
                                                              CH3



  fispemifenum
  fispemifene                                2-(2-{4-[(1Z)-4-chloro-1,2-diphenylbut-1-enyl]phenoxy}=
                                             ethoxy)ethanol

  fispémifène                                2-[2-[4-[(1Z)-4-chloro-1,2-diphénylbut-1-ényl]phénoxy]=
                                             éthoxy]éthanol

  fispemifeno                                2-(2-{4-[(1Z)-4-cloro-1,2-difenilbut-1-enil]fenoxi}etoxi)etanol




                                                                                                                                      95
Recommended INN: List 51                                    WHO Drug Information, Vol. 18, No. 1, 2004




                           C26H27ClO3



                                                            O                OH
                                                                    O

                           Cl




 fluoresceinum lisicolum
 fluorescein lisicol       N6-({3',6'-dihydroxy-3-oxospiro[isobenzofuran-1(3H),9'-xanthen]-
                           5-yl}thiocarbamoyl)-N2-(3α,7α,12α-trihydroxy-5β-cholan-24-oyl)-
                           L-lysine

 fluorescéine lisicol      acide (2S)-6-[[(3',6'-dihydroxy-3-oxospiro[isobenzofurane-
                           1(3H),9'-[9H]xanthén]-5-yl)thiocarbamoyl]amino]-2-[(3α,7α,12α-
                           trihydroxy-5β-cholan-24-oyl)amino]pentanoïque

 fluoresceina lisicol      ácido 5-[({(5S)-5-carboxi-5-[(3α,7α,12α-trihidroxi-5β-colan-
                           24-oil)amino]pentil}tiocarbamoil)amino]-2-(6-hidroxi-3-oxo-
                           3H-xanten-9-il)benzoico

                           C51H63N3O11S

                                                                                        S
                                                                    O
                                                                                    N       NH
                                                     H 3C    H                      H
                                                 H                  HN
                                            HO       CH3                     CO2H
                                                                         H
                                                                H
                                                                                                     O
                                        CH3      H
                                                                             HO                  O
                                             H       H
                           HO                        H
                                                                                        O
                                H       H            OH

                                                                                                     OH

 freselestatum
 freselestat               2-[5-amino-6-oxo-2-phenylpyrimidin-1(6H)-yl]-N-[(1RS)-1-(5-tert-
                           butyl-1,3,4-oxadiazol-2-yl)-3-methyl-1-oxobutan-2-yl]acetamide

 frésélestat               2-(5-amino-6-oxo-2-phénylpyrimidin-1(6H)-yl)-N-[(1RS)-1-[[5-(1,1-
                           diméthyléthyl)-1,3,4-oxadiazol-2-yl]carbonyl]-2-méthylpropyl]=
                           acétamide

 freselestat               2-[5-amino-6-oxo-2-fenilpirimidin-1(6H)-il]-N-[(1RS)-1-(5-terc-butil-
                           1,3,4-oxadiazol-2-il)-3-metil-1-oxobutan-2-il]acetamida




96
WHO Drug Information, Vol. 18, No. 1, 2004                                                            Recommended INN: List 51




                                             C23H28N6O4




                                              H3C   CH 3            O
                                                                         H                     and enantiomer
                                                           O             N                     et énanti omère
                                             H3C                                     N       N y enantiómero
                                                                    H
                                                      N N                  O
                                                               H 3C      CH3 O
                                                                                         NH 2


  galiximabum
  galiximab                                  immunoglobulin G1, anti-(human CD80 (antigen)) (human-Macaca
                                             irus monoclonal IDEC-114 heavy chain), disulfide with human-
                                             Macaca irus monoclonal IDEC-114 λ chain, dimer

  galiximab                                  immunoglobuline G1, anti-(antigène CD80 humain), dimère du
                                             disulfure entre la chaîne λ et la chaîne lourde de l’anticorps
                                             monoclonal chimérique homme- macaque (Macaca irus) IDEC-114

  galiximab                                  inmunoglobulina G1, anti-(antígeno CD80 humano), dímero del
                                             disulfuro entre la cadena λ y la cadena pesada del anticuerpo
                                             monoclonal quimérico hombre-macaco (Macaca irus) IDEC-114



  hemoglobinum raffimerum
  hemoglobin raffimer                        The polyaldehyde [(2R,4S,6R,8R,11S,13R)-1,14-dihydroxy-
                                             4-hydroxymethyl-3,5,7,10,12-pentaoxatetradecane-2,4,6,8,11,13-
                                             hexacarbaldehyde] derived from raffinose [β-D -fructofuranosyl
                                             α- D-galactopyranosyl-(1→6)-α-D -glucopyranoside] by treatment
                                             with sodium periodate is reacted with human hemoglobin A 0 at the
                                             2,3-DPG binding pocket. Both intermolecular and intramolecular
                                             crosslinking occurs. This product is reduced to generate covalent
                                             amine bonds with >95% crosslinked hemoglobin of which about
                                             55% is polymerised.

  hémoglobine raffimer                       hémoglobine stabilisée et partiellement polymérisée, obtenue par
                                             réduction du produit de la réaction du (2R,4S,6R,8R,11S,13R)-
                                             1,14-dihydroxy-4-(hydroxyméthyl)-3,5,7,10,12-
                                             pentaoxatétradécane-2,4,6,8,11,13-hexacarbaldéhyde (obtenu par
                                             oxydation periodique du rafinose) avec l'hémoglobine humaine

  hemoglobina rafímero                       hemoglobina estabilizada y parcialmente polimerizada, obtenida por
                                             reducción del producto de la reacción del (2R,4S,6R,8R,11S,13R)-
                                             1,14-dihidroxi-4-(hidroximetil)-3,5,7,10,12-pentaoxatetradecano-
                                             2,4,6,8,11,13-hexacarbaldehído (obtenido por oxidación periodica
                                             de la rafinosa) con la hemoglobina humana


                                                                                 1                OH
                                                                             Val (βHb)
                                                                    HO   HN
                                                                                         O
                                                       O            O                             N      82
                                             HO                              O       O                 Lys (βHb)
                                                                                             OH
                                                       N
                                                               82
                                                       Lys (β'Hb)



                                                                                                                           97
Recommended INN: List 51                                    WHO Drug Information, Vol. 18, No. 1, 2004




 icofungipenum
 icofungipen               (1R,2S)-2-amino-4-methylenecyclopentane-1-carboxylic acid

 icofungipen               (-)-acide (1R,2S)-2-amino-4-méthylènecyclopentanecarboxylique

 icofungipeno              (-)-ácido (1R,2S)-2-amino-4-metilenociclopentanocarboxílico

                           C7H11NO2

                                    CH2




                           H2N             CO 2H
                                  H H



 icrocaptidum
 icrocaptide               glycyl-N2-ethyl- L-lysyl- L-prolyl- L-arginine

 icrocaptide               glycyl-(N2-éthyl- L-lysyl)- L-prolyl-L-arginine

 icrocaptida               glicil-(N2-etil- L-lisil)- L-prolil- L-arginina

                           C21H40N8O5

                                                             H
                                   H3C                  O    N       CO2H
                                                  O
                                                             H
                                          N                          H
                           H2N                         N
                                     O            H
                                                                         NH2
                                                                 N
                                                                         NH2
                                                      NH2


 iferanserinum
 iferanserin               (E)-2'- {2-[(2S)-1-methyl-2-piperidyl]ethyl}cinnamanilide

 iféransérine              (-)-(2E)-N-[2-[2-[(2S)-1-méthylpipéridin-2-yl]éthyl]phényl]-
                           3-phénylprop-2-énamide

 iferanserina              (-)-(2E)-N-(2-{2-[(2S)-1-metilpiperidin-2-il]etil}fenil)-3-fenilprop-
                           2-enamida

                           C23H28N2O

                                              O

                                                      NH
                                                             H
                                                                     N
                                                                     CH3




98
WHO Drug Information, Vol. 18, No. 1, 2004                                                     Recommended INN: List 51




  istradefyllinum
  istradefylline                             8-[(E)-2-(3,4-dimethoxyphenyl)vinyl]-1,3-diethyl-7-methyl-
                                             3,7-dihydro-1H-purin-2,6-dione

  istradéfylline                             8-[(E)-2-(3,4-diméthoxyphényl)éthényl]-1,3-diéthyl-7-méthyl-
                                             3,7-dihydro-1H-purin-2,6-dione

  istradefilina                              8-[(E)-2-(3,4-dimetoxifenil)vinil]-1,3-dietil-7-metil-3,7-dihidro-
                                             1H-purin-2,6-diona

                                             C20H24N4O4

                                                            O            CH3
                                                                       N                OCH3
                                             H3C        N

                                                    O       N          N                  OCH3

                                                                   CH3


  ixabepilonum
  ixabepilone                                (1S,3S,7S,10R,11S,12S,16R)-7,11-dihydroxy-8,8,10,12,16-
                                             pentamethyl-3-[(1E)-1-(2-methyl-1,3-thiazol-4-yl)prop-1-en-2-yl]-
                                             17-oxa-4-azabicyclo[14.1.0]heptadecane-5,9-dione

  ixabépilone                                (1S,3S,7S,10R,11S,12S,16R)-7,11-dihydroxy-8,8,10,12,16-
                                             pentaméthyl-3-[(1E)-1-méthyl-2-(2-méthylthiazol-4-yl)éthényl]-
                                             17-oxa-4-azabicyclo[14.1.0]heptadécane-5,9-dione

  ixabepilona                                (1S,3S,7S,10R,11S,12S,16R)-7,11-dihidroxi-8,8,10,12,16-
                                             pentametil-3-[(1E)-1-(2-metil-1,3-tiazol-4-il)prop-1-en-2-il]-17-oxa-
                                             4-azabiciclo[14.1.0]heptadecano-5,9-diona

                                             C27H42N2O5S

                                                                   H3C
                                                                           O
                                                                               H CH3      S
                                                    H       H
                                              HO                                               CH3
                                                        CH3                              N
                                                H   H3C   CH3                       H
                                                                               NH
                                             H3C
                                                               H
                                                        O          OH      O

  ladostigilum
  ladostigil                                 (3R)-3-(prop-2-ynylamino)indan-5-yl ethyl(methyl)carbamate

  ladostigil                                 éthylméthylcarbamate de (3R)-3-(prop-2-ynylamino)-2,3-dihydro-
                                             1H-indén-5-yle

  ladostigilo                                etilmetilcarbamato de (3R)-3-(prop-2-inilamino)indan-5-ilo

                                             C16H20N2O2

                                                            O

                                             H3C        N          O
                                                                                    N
                                                        CH 3                   H
                                                                                    H
                                                                                         CH



                                                                                                                     99
Recommended INN: List 51                                  WHO Drug Information, Vol. 18, No. 1, 2004




 lapatinibum
 lapatinib                 N-[3-chloro-4-(3-fluorobenzyloxy)phenyl]-6-[5-({[2-(methylsulfonyl)=
                           ethyl]amino}methyl)-2-furyl]quinazolin-4-amine

 lapatinib                 N-[3-chloro-4-[(3-fluorobenzyl)oxy]phenyl]-6-[5-[[[2-
                           (methylsulfonyl)ethyl]amino]methyl]-2-furyl]quinazolin-4-amine

 lapatinib                 N-[3-cloro-4-(3-fluorobenciloxi)fenil]-6-[5-({[2-(metilsulfonil)=
                           etil]amino}metil)-2-furil]quinazolin-4-amina

                           C29H26ClFN4O4S

                                                                     N

                                                      O                  N
                                    O
                             O               NH                     HN         Cl
                                 S
                           H3C                                                                 F
                                                                               O




 lomeguatribum
 lomeguatrib               6-(4-bromothenyloxy)-7H-purin-2-amine

 lomeguatrib               6-[(4-bromothiophen-2-yl)methoxy]-7H-purin-2-amine

 lomeguatrib               6-(4-bromoteniloxi)-7H-purin-2-amina

                           C10H8BrN5OS

                                S
                                            O
                                                  H
                                                  N
                                        N
                           Br
                                 H2N         N    N




 odiparcilum
 odiparcil                 4-methyl-7-(5-thio-β-D -xylopyranosyloxy)-2H-chromen-2-one

 odiparcil                 4-méthyl-7-[(5-thio-β-D -xylopyranosyl)oxy]- 2H-1-benzopyran-2-one

 odiparcilo                4-metil-7-(5-tio-β- D-xilopiranosiloxi)-2H-cromen-2-ona

                           C15H16O6S

                                        S O               O     O
                                 OH
                           HO
                                        OH                CH3




100
WHO Drug Information, Vol. 18, No. 1, 2004                                                           Recommended INN: List 51




  omigananum
  omiganan                                   L-isoleucyl- L-leucyl- L-arginyl L-tryptophyl-L-prolyl- L-tryptophyl-
                                                                            -
                                             L-tryptophyl- L-prolyl-L-tryptophyl- L-arginyl- L-arginyl-L-lysinamide

  omiganan                                   L-isoleucyl- L-leucyl- L-arginyl L-tryptophyl-L-prolyl- L-tryptophyl-
                                                                            -
                                             L-tryptophyl- L-prolyl-L-tryptophyl- L-arginyl- L-arginyl-L-lysinamide

  omiganán                                   L-isoleucil- L-leucil- L-arginil- L-triptofil- L-prolil- L-triptofil- L-triptofil-
                                             L-prolil- L-triptofil- L-arginil- L-arginil- L-lisinamida

                                             C90H127N27O12

                                             H Ile       Leu   Arg Trp     Pro      Trp Tr p Pro Trp         Arg   Arg    Lys NH 2
                                                                                                             10


  pactimibum
  pactimibe                                  [7-(2,2-dimethylpropanamido)-4,6-dimethyl-1-octylindolin-5-yl]acetic
                                             acid

  pactimibe                                  acide [7-[(2,2-diméthylpropanoyl)amino]-4,6-diméthyl-1-octyl-
                                             2,3-dihydro-1H-indol-5-yl]acétique

  pactimiba                                  ácido [7-(2,2-dimetilpropanamido)-4,6-dimetil-1-octilindolin-5-il]
                                             acético

                                             C25H40N2O3

                                                                                     CH3

                                                                                                 CO2H

                                                                           N                CH3
                                                                                   HN      O

                                                                                            CH3
                                             H3C                                   H 3C
                                                                                           CH3


  patupilonum
  patupilone                                 (1S,3S,7S,10R,11S,12S,16R)-7,11-dihydroxy-8,8,10,12,16-
                                             pentamethyl-3-[(1E)-1-(2-methyl-1,3-thiazol-4-yl)prop-1-en-2-yl]-
                                             4,17-dioxabicyclo[14.1.0]heptadecane-5,9-dione

  patupilone                                 (1S,3S,7S,10R,11S,12S,16R)-7,11-dihydroxy-8,8,10,12,16-
                                             pentaméthyl-3-[(1E)-1-méthyl-2-(2-méthylthiazol-4-yl)éthényl]-
                                             4,17-dioxabicyclo[14.1.0]heptadécane-5,9-dione

  patupilona                                 (1S,3S,7S,10R,11S,12S,16R)-7,11-dihidroxi-8,8,10,12,16-
                                             pentametil-3-[(1E)-1-(2-metil-1,3-tiazol-4-il)prop-1-en-2-il]-
                                             4,17-dioxabiciclo[14.1.0]heptadecano-5,9-diona

                                             C27H41NO6S

                                                                   H3C
                                                                         O
                                                                               H CH3             S
                                                     H         H
                                              HO                                                     CH3
                                                         CH3                                   N
                                                H    H3C   CH3                      H
                                                                               O
                                             H3C
                                                               H
                                                          O        OH    O


                                                                                                                                     101
Recommended INN: List 51                             WHO Drug Information, Vol. 18, No. 1, 2004




 pertuzumabum
 pertuzumab                immunoglobulin G1, anti-(human ν (receptor)) (human-mouse
                           monoclonal 2C4 heavy chain), disulfide with human-mouse
                           monoclonal 2C4 κ-chain, dimer

 pertuzumab                immunoglobuline G1, anti-(récepteur ν humain), dimère du disulfure
                           entre la chaîne κ et la chaîne lourde de l’anticorps monoclonal de
                           souris humanisé 2C4

 pertuzumab                inmunoglobulina G1, anti-(receptor ν humano), dímero del disulfuro
                           entre la cadena κ y la cadena pesada del anticuerpo monoclonal
                           humanizado de ratón 2C4


 pixantronum
 pixantrone                6,9-bis[(2-aminoethyl)amino]benzo[g]isoquinoline-5,10-dione

 pixantrone                6,9-bis[(2-aminoéthyl)amino]benzo[g]isoquinoléine-5,10-dione

 pixantrona                6,9-bis[(2-aminoetil)amino]benzo[g]isoquinolina-5,10-diona

                           C17H19N5O2

                                                     NH2
                                    O   HN



                           N

                                    O   HN
                                                     NH2



 pritumumabum
 pritumumab                immunoglobulin G, anti-(human vimentin) (human monoclonal CLN
                           G11 γ1-chain), disulfide with human monoclonal CLN G11 κ-chain,
                           dimer

 pritumumab                immunoglobuline G, anti-(vimentine humaine) ; dimère du disulfure
                           entre la chaîne γ1 et la chaîne κ de l'anticorps monoclonal humain
                           CLN H11

 pritumumab                inmunoglobulina G, anti-(vimentina humana); dímero del disulfuro
                           entre la cadena γ1 y la cadena κ del anticuerpo monoclonal humano
                           CLN H11

                           C6440H9968N1708O2016S42




 ralfinamidum
 ralfinamide               (2S)-2-[4-(2-fluorobenzyloxy)benzylamino]propanamide

 ralfinamide               (+)-(2S)-2-[[4-[(2-fluorobenzyl)oxy]benzyl]amino]propanamide

 ralfinamida               (+)-(2S)-2-[4-(2-fluorobenciloxi)bencilamino]propanamide




102
WHO Drug Information, Vol. 18, No. 1, 2004                                                               Recommended INN: List 51




                                             C17H19FN2O2

                                                                                      H CH3
                                                                                                 NH2
                                                                                     N
                                                                                     H
                                                                                            O
                                                                O

                                                        F



  rebimastatum
  rebimastat                                 N-[(2S)-2-sulfanyl-4-(3,4,4-trimethyl-2,5-dioxoimidazolidin-
                                             1-yl)butanoyl]-L-leucyl-N1,3-dimethyl- L-valinamide

  rébimastat                                 (2S)-N-[(1S)-2,2-diméthyl-1-(méthylcarbamoyl)propyl]-4-méthyl-
                                             2-[[(2S)-2-sulfanyl-4-(3,4,4-triméthyl-2,5-dioxoimidazolidin-
                                             1-yl)butanoyl]amino]pentanamide

  rebimastat                                 N-[(2S) -2-sulfanil-4-(3,4,4-trimetil-2,5-dioxoimidazolidin-
                                             1-il)butanoil]- L-leucil-N1,3-dimetil- L-valinamida

                                             C23H41N5O5S

                                                                                           CH3
                                                        CH 3
                                                 H 3C               O               H3C
                                                                                    O H                 O
                                                    N                                            H
                                             H3C                N                                N             CH 3
                                                                                 N                        N
                                                                                                        H H
                                                        O                   H SH H         O
                                                                                                        CH 3
                                                                                            H 3C
                                                                                                       CH 3


  segesteronum
  segesterone                                17-hydroxy-16-methylene-19-norpregn-4-ene-3,20-dione

  ségestérone                                17-hydroxy-16-méthylène-19-norprégn-4-ène-3,20-dione

  segesterona                                17-hidroxi-16-metileno-19-norpregn-4-eno-3,20-diona

                                             C21H28O3

                                                                                O
                                                                                     CH3
                                                                            CH3
                                                                                    OH
                                                            H           H            CH2

                                                                H           H
                                             O

  semapimodum
  semapimod                                  N,N'-bis{3,5-bis[1-(carbamimidoylhydrazono)ethyl]phenyl}=
                                             decanediamide

  sémapimod                                  N,N'-bis[3,5-bis[N-(carbamimidoylamino)acétimidoyl]phényl]=
                                             décanediamide

  semapimod                                  N,N'-bis{3,5-bis[1-(carbamimidoilhidrazono)etil]fenil}=
                                             decanodiamida



                                                                                                                             103
Recommended INN: List 51                                      WHO Drug Information, Vol. 18, No. 1, 2004




                           C34H52N18O2

                                                                                             CH 3        CH3
                                                                                     H                         H
                                                                        H2 N         N                         N        NH 2
                                                                                         N                 N
                                                                                   NH                              NH
                                                          O
                                                                                                    NH
                                                     HN
                                                                                                O
                                  NH                                        NH
                                           N                    N
                           H2 N        N                                N          NH2
                                       H                                H
                                               CH3            CH3




 sufugolixum
 sufugolix                 5-{[benzyl(methyl)amino]methyl}-1-(2,6-difluorobenzyl)-6-[4-
                           (3-methoxyureido)phenyl]-3-phenylthieno[2,3-d]pyrimidine-
                           2,4(1H,3H)-dione

 sufugolix                 1-[4-[5-[(benzylméthylamino)méthyl]-1-(2,6-difluorobenzyl)-
                           2,4-dioxo-3-phényl-1,2,3,4-tétrahydrothiéno[2,3-d]pyrimidin-
                           6-yl]phényl]-3-méthoxyurée

 sufugolix                 5-{[bencil(metil)amino]metil}-1-(2,6-difluorobencil)-6-[4-
                           (3-metoxiureido)fenil]-3-feniltieno[2,3-d]pirimidina-2,4(1H,3H)-diona

                           C36H31F2N5O4S

                                                                               F



                           H3C    O            O
                                                                    F
                                  HN                                S          N         O
                                           HN
                                                                                    N

                                                                               O
                                                                    N
                                                               H3C




 tacapenemum
 tacapenem                 (+)-(4R,5S,6S)-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-3-[[(3R)-5-
                           oxopyrrolidin-3-yl]sulfanyl]-1-azabicyclo[3.2.0]hept-2-ene-
                           2-carboxylic acid

 tacapénem                 (+)-acide (4R,5S,6S)-6-[(1R)-1-hydroxyéthyl]-4-méthyl-7-oxo-
                           3-[[(3R)-5-oxopyrrolidin-3-yl]sulfanyl]-1-azabicyclo[3.2.0]hept-2-ène-
                           2-carboxylique

 tacapenem                 (+)-ácido (4R,5S,6S)-6-[(1R)-1-hidroxietil]-4-metil-7-oxo-3-[[(3R)-5-
                           oxopirrolidin-3-il]sulfanil]-1-azabiciclo[3.2.0]hept-2-eno-2-carboxílico




104
WHO Drug Information, Vol. 18, No. 1, 2004                                                      Recommended INN: List 51




                                             C14 H1 8N2O5 S

                                                                CO 2H
                                                   O
                                             H3C            N
                                                              S
                                             HO             H
                                                   H H H                        O
                                                         H CH3
                                                                            N
                                                                            H



  tafluprostum
  tafluprost                                 isopropyl (5Z)-7-{(1R,2R,3R,5S)-2-[(1E)-3,3-difluoro-4-phenoxybut-
                                             1-enyl]-3,5-dihydroxycyclopentyl}hept-5-enoate

  tafluprost                                 (5Z)-7-[(1R,2R,3R,5S)-2-[(1E)-3,3-difluoro-4-phénoxybut-1-ényl]-
                                             3,5-dihydroxycyclopentyl]hept-5-énoate de 1-méthyléthyle

  tafluprost                                 (5Z)-7-{(1R,2R,3R,5S)-2-[(1E)-3,3-difluoro-4-fenoxibut-1-enil]-
                                             3,5-dihidroxiciclopentil}hept-5-enoato de isopropilo

                                             C25H34F2O5

                                                   OH
                                               H        H
                                                                                    O     CH3

                                                                                O       CH3
                                                                        O
                                             HO         H
                                                   H            F   F




  talizumabum
  talizumab                                  immunoglobulin G, anti-(human immunoglobulin E Fc region)
                                             (human-mouse monoclonal Hu901 γ-chain), disulfide with human-
                                             mouse monoclonal Hu901 κ-chain, dimer

  talizumab                                  immunoglobuline G, anti-(région Fc de l’immunoglobuline E
                                             humaine), dimère du disulfure entre la chaîne κ et la chaîne γ de
                                             l’anticorps monoclonal de souris humanisé Hu901

  talizumab                                  inmunoglobulina G, anti-(región Fc de la inmunoglobulina E
                                             humana), dímero del disulfuro entre la cadena κ y la cadena γ del
                                             anticuerpo monoclonal humanizado de ratón Hu901



  technetium (99mTc) nitridocadum
  technetium (99mTc) nitridocade             (SPY-5-21)-bis[ethoxy(ethyl)dithiocarbamato-κS,κS']nitrido=
                                             [99mTc]technetium

  technétium (99mTc) nitridocade             (SPY-5-21)-bis(éthoxyéthyldithiocarbamato-κS,κS')nitrido=
                                             [99mTc]technétium

  tecnecio (99mTc) nitridocado               (SPY-5-21)-bis(etoxietilditiocarbamato-κS,κS')nitrido[99m Tc]tecnecio




                                                                                                                    105
Recommended INN: List 51                                        WHO Drug Information, Vol. 18, No. 1, 2004




                           C10H20N3O2S499mTc

                           H3C                                                 CH3
                                                 S         N    S
                                   O                                      O
                                                     99m
                                        N                  Tc         N
                             H3C                 S              S             CH3


 tesofensinum
 tesofensine               (1R,2R,3S,5S)-3-(3,4-dichlorophenyl)-2-(ethoxymethyl)-8-methyl-
                           8-azabicyclo[3.2.1]octane

 tésofensine               (1R,2R,3S,5S)-3-(3,4-dichlorophényl)-2-(éthoxyméthyl)-8-méthyl-
                           8-azabicyclo[3.2.1]octane

 tesofensina               (1R,2R,3S,5S)-3-(3,4-diclorofenil)-2-(etoximetil)-8-metil-
                           8-azabiciclo[3.2.1]octano

                           C17H23Cl2 NO

                                                     H

                                        H
                                                         N CH3

                                            H
                           Cl                        H
                                            O
                                   Cl
                                                 CH3


 tifenazoxidum
 tifenazoxide              6-chloro-N-(1-methylcyclopropyl)-1,1-dioxo-1,4-dihydro-1λ6-
                           thieno[3,2-e][1,2,4]thiadiazin-3-amine

 tifénazoxide              1,1-dioxyde de 6-chloro-N-(1-méthylcyclopropyl)-4H-thiéno[3,2-e]-
                           1,2,4-thiadiazin-3-amine

 tifenazóxido              1,1-dióxido de 6-cloro-N-(1-metilciclopropil)-4H-tieno[3,2-e]-1,2,4-
                           tiadiazin-3-amina

                           C9H10ClN3O2S2

                                            O O
                                   S         S
                                               N
                           Cl
                                             N         N        CH3
                                             H         H



 tisocalcitatum
 tisocalcitate             isopropyl (1S,3R,5Z,7E,22E,24R)-1,3,24-trihydroxy-
                           9,10-secocholesta-5,7,10(19),22-tetraene-25-carboxylate

 tisocalcitate             (5Z,7E,22E,24R)-1α,3β,24-trihydroxy-9,10-sécocholesta-
                           5,7,10(19),22-tétraène-25-carboxylate de 1-méthyléthyle

 tisocalcitato             (1S,3R,5Z,7E,22E,24R)-1,3,24-trihidroxi-9,10-secocolesta-
                           5,7,10(19),22-tetraeno-25-carboxilato de isopropilo




106
WHO Drug Information, Vol. 18, No. 1, 2004                                                     Recommended INN: List 51




                                             C31H48O5

                                                           H3C H               H
                                                                                   OH
                                                                                        O
                                                           CH3                               CH3
                                                                       H
                                                                           H3C           O
                                                                                   CH3       CH3
                                                            H


                                                           CH2

                                             HO               OH
                                                  H       H



  ulifloxacinum
  ulifloxacin                                (1RS)-6-fluoro-1-methyl-4-oxo-7-(piperazin-1-yl)-
                                             4H-[1,3]thiazeto[3,2-a]quinoline-3-carboxylic acid

  ulifloxacin                                acide (1RS)-6-fluoro-1-méthyl-4-oxo-7-(pipérazin-1-yl)-
                                             4H-[1,3]thiazéto[3,2-a]quinoléine-3-carboxylique

  ulifloxacino                               ácido (1RS)-6-fluoro-1-metil-4-oxo-7-(piperazin-1-il)-
                                             4H-[1,3]tiazeto[3,2-a]quinolina-3-carboxílico

                                             C16H16FN3O3S

                                                                   H CH3
                                             HN
                                                                           S        and enantiomer
                                                      N            N
                                                                                    et énantiomère
                                                                                    y enantiómero
                                                      F                    CO 2H
                                                                   O

  vareniclinum
  varenicline                                7,8,9,10-tetrahydro-6H-6,10-methanoazepino[4,5-g]quinoxaline

  varénicline                                (6R,10S)-7,8,9,10-tétrahydro-6,10-méthano-6H-pyrazino[2,3-
                                             h][3]benzazépine

  vareniclina                                7,8,9,10-tetrahidro-6H-6,10-metanoazepino[4,5-g]quinoxalina

                                             C13H13N3

                                                      H
                                                                   N
                                             HN
                                                                   N
                                                      H




                                                                                                                   107
Recommended INN: List 51                                               WHO Drug Information, Vol. 18, No. 1, 2004




                           AMENDMENTS TO PREVIOUS LISTS
                   MODIFICATIONS APPORTÉES AUX LISTES ANTÉRIEURES
                       MODIFICACIONES A LAS LISTAS ANTERIORES


Recommended International Nonproprietary Names (Rec. INN): List 04
Dénominations communes internationales recommandées (DCI Rec.): Liste 04
Denominaciones Comunes Internacionales Recomendadas (DCI Rec.): Lista 04
(Crónica de la OMS, Vol. 16, N° 4, Abril de 1962)

p. 158   suprimase                 insértese
         metodilazina              metdilazina



Recommended International Nonproprietary Names (Rec. INN): List 06
Dénominations communes internationales recommandées (DCI Rec.): Liste 06
Denominaciones Comunes Internacionales Recomendadas (DCI Rec.): Lista 06
(WHO Chronicle, Vol. 20, No. 11, 1967)
(Chronique OMS, Vol. 20, N° 11, 1967)
(Crónica de la OMS, Vol. 21, N° 11, 1967)

         lauromacrogolum 400
p. 427   lauromacrogol 400          replace the description by the following:
                                    polyethylene glycol monododecyl ether, the name is followed by a number (400)
                                    corresponding approximately to the average molecular mass of the polyethylene
                                    glycol portion

p. 474   lauromacrogol 400          remplacer la description par la suivante:
                                    α-dodécyl-ω-hydroxypoly(oxyéthylène), la masse moyenne de la partie macrogol
                                    (# 44n+18) est indiquée entre parenthèses après la dénomination

p. 340   lauromacrogol 400          sustitúyase la descripción por la siguiente:
                                    éter monododecílico del polietilen glicol, al nombre le sigue un número (400) que
                                    corresponde aproximadamente a la masa molecular media de la fracción
                                    polietilenglicol


Recommended International Nonproprietary Names (Rec. INN): Lis t 40
Dénominations communes internationales recommandées (DCI Rec.): Liste 40
Denominaciones Comunes Internacionales Recomendadas (DCI Rec.): Lista 40
(WHO Drug Information, Vol. 12, No. 3, 1998)

p. 194   supprimer                 insérer
         pregabaline               prégabaline




108
    WHO Drug Information, Vol. 18, No. 1, 2004                                               Recommended INN: List 51




Procedure and Guiding Principles / Procédure et Directives / Procedimientos y principios generales
The text of the Procedures for the Selection of Recommended International Nonproprietary Names for Pharmaceutical
Substances and General Principles for Guidance in Devising International Nonproprietary Names for Pharmaceutical
Substances will be reproduced in uneven numbers of proposed INN lists only.
Les textes de la Procédure à suivre en vue du choix de dénominations communes internationales recommandées pour les
substances pharmaceutiques et des Directives générales pour la formation de dénominations communes internationales
applicables aux substances pharmaceutiques seront publiés seulement dans les numéros impairs des listes des DCIs
proposées.
El texto de los Procedimientos de selección de denominaciones comunes internacionales recomendadas para las sustancias
farmacéuticas y de los Principios generales de orientación para formar denominaciones comunes internacionales para
sustancias farmacéuticas aparece solamente en los números impares de las listas de DCI propuestas.



                                                                                                                    109
